Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 709 $ 341
Accounts receivable and contract assets, net of allowance for doubtful accounts of $32 million and $25 million, respectively 74 183
Other current assets 80 33
Total current assets 863 557
Property and equipment, net 145 155
Intangible assets not subject to amortization:    
Goodwill (note 5) 2,214 2,527
Trademarks (note 5) 725 980
Intangible assets not subject to amortization 2,939 3,507
Intangible assets subject to amortization, net 237 277
Other assets, at cost, net of accumulated amortization 209 230
Total assets 4,393 4,726
Current liabilities:    
Deferred merchant and other payables 70 170
Deferred revenue 38 62
Accrued liabilities and other current liabilities 142 205
Total current liabilities 250 437
Long-term debt (note 6) 740 353
Deferred income tax liabilities 193 254
Other liabilities 374 381
Total liabilities 1,557 1,425
Redeemable preferred stock, $.01 par value. Authorized shares 50,000,000; issued and outstanding 325,000 shares at June 30, 2020 and 0 at December 31, 2019 (note 7) 354
Equity:    
Additional paid-in capital 244 237
Accumulated other comprehensive earnings (loss), net of taxes (32) (29)
Retained earnings (103) 111
Total stockholders' equity 110 320
Noncontrolling interests in equity of subsidiaries 2,372 2,981
Total equity 2,482 3,301
Commitments and contingencies (note 9)
Total liabilities, redeemable preferred stock and equity 4,393 4,726
Series A    
Equity:    
Common stock value 1 1
Series B    
Equity:    
Common stock value
Series C    
Equity:    
Common stock value